137 related articles for article (PubMed ID: 22230980)
21. Epidemiology and classification for canine and feline mammary gland tumors: a histopathological survey of 437 mammary gland tumor biopsies performed in a secondary care hospital in Chiang Mai, Thailand from 2012 to 2019.
Srisawat W; Pringproa K; Prachasilchai W; Thongtharb A; Sthitmatee N
PeerJ; 2024; 12():e17077. PubMed ID: 38500523
[TBL] [Abstract][Full Text] [Related]
22. Thyroglobulin as a negative marker for malignancy in canine and human breast tumors.
Hwang SH; Yang Y; Woo SH; Jung JH; Seo D; Kim DY; Kim Y
Mol Carcinog; 2021 Jul; 60(7):455-468. PubMed ID: 34003526
[TBL] [Abstract][Full Text] [Related]
23. Repeatable and objective method for evaluating angiogenesis using real-time RT-PCR of endoglin expression in canine tumours.
Kimura M; Yamasaki M; Satoh H; Uchida N
Vet Comp Oncol; 2021 Mar; 19(1):34-43. PubMed ID: 32592434
[TBL] [Abstract][Full Text] [Related]
24. Expression of inflammation-mediated cluster of genes as a new marker of canine mammary malignancy.
Pawłowski KM; Homa A; Bulkowska M; Majchrzak K; Motyl T; Król M
Vet Res Commun; 2013 Jun; 37(2):123-31. PubMed ID: 23435839
[TBL] [Abstract][Full Text] [Related]
25. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
Ahern TE; Bird RC; Bird AE; Wolfe LG
Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Hypoxia-Inducible Factor-1α Expression Relative to Other Key Factors in Malignant Canine Mammary Tumours.
Shin JI; Lim HY; Kim HW; Seung BJ; Sur JH
J Comp Pathol; 2015; 153(2-3):101-10. PubMed ID: 26145724
[TBL] [Abstract][Full Text] [Related]
27. Survivin and related proteins in canine mammary tumors: immunohistochemical expression.
Bongiovanni L; Romanucci M; Malatesta D; D'Andrea A; Ciccarelli A; Della Salda L
Vet Pathol; 2015 Mar; 52(2):269-75. PubMed ID: 24686389
[TBL] [Abstract][Full Text] [Related]
28. Five markers useful for the distinction of canine mammary malignancy.
Pawłowski KM; Maciejewski H; Majchrzak K; Dolka I; Mol JA; Motyl T; Król M
BMC Vet Res; 2013 Jul; 9():138. PubMed ID: 23844591
[TBL] [Abstract][Full Text] [Related]
29. Significance of caveolin-1 and matrix metalloproteinase 14 gene expression in canine mammary tumours.
Ebisawa M; Iwano H; Nishikawa M; Tochigi Y; Komatsu T; Endou Y; Hirayama K; Taniyama H; Kadosawa T; Yokota H
Vet J; 2015 Nov; 206(2):191-6. PubMed ID: 26364240
[TBL] [Abstract][Full Text] [Related]
30. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of accuracy of fine needle aspiration cytology for diagnosis of canine mammary tumours: comparative features with human tumours.
Cassali GD; Gobbi H; Malm C; Schmitt FC
Cytopathology; 2007 Jun; 18(3):191-6. PubMed ID: 17573766
[TBL] [Abstract][Full Text] [Related]
32. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?
Burrai GP; Tanca A; De Miglio MR; Abbondio M; Pisanu S; Polinas M; Pirino S; Mohammed SI; Uzzau S; Addis MF; Antuofermo E
Tumour Biol; 2015 Nov; 36(11):9083-91. PubMed ID: 26088453
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical and quantitative RT-PCR methods to assess RANK expression in normal and neoplastic canine mammary gland.
Sánchez-Céspedes R; Millan Y; Guil-Luna S; García-Macías J; Maniscalco L; Iussich S; De Maria R; M de Las Mulas J
J Vet Diagn Invest; 2018 Jan; 30(1):155-160. PubMed ID: 29020879
[TBL] [Abstract][Full Text] [Related]
34. Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry.
Peña L; Gama A; Goldschmidt MH; Abadie J; Benazzi C; Castagnaro M; Díez L; Gärtner F; Hellmén E; Kiupel M; Millán Y; Miller MA; Nguyen F; Poli A; Sarli G; Zappulli V; de las Mulas JM
Vet Pathol; 2014 Jan; 51(1):127-45. PubMed ID: 24227007
[TBL] [Abstract][Full Text] [Related]
35. Oestrogen and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs.
Mainenti M; Rasotto R; Carnier P; Zappulli V
Vet J; 2014 Oct; 202(1):62-8. PubMed ID: 24980810
[TBL] [Abstract][Full Text] [Related]
36. Analysis of lysyl oxidase as a marker for diagnosis of canine mammary tumors.
Saleem A; Singh S; Sunil Kumar BV; Arora JS; Choudhary RK
Mol Biol Rep; 2019 Oct; 46(5):4909-4919. PubMed ID: 31264163
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors.
Moschetta MG; Maschio LB; Jardim-Perassi BV; Gelaleti GB; Lopes JR; Leonel C; Gonçalves Ndo N; Ferreira LC; Martins GR; Borin TF; Zuccari DA
Oncol Rep; 2015 May; 33(5):2345-53. PubMed ID: 25779537
[TBL] [Abstract][Full Text] [Related]
38. Hormone Receptor Expression Analyses in Neoplastic and Non-Neoplastic Canine Mammary Tissue by a Bead Based Multiplex Branched DNA Assay: A Gene Expression Study in Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Samples.
Mohr A; Lüder Ripoli F; Hammer SC; Willenbrock S; Hewicker-Trautwein M; Kiełbowicz Z; Murua Escobar H; Nolte I
PLoS One; 2016; 11(9):e0163311. PubMed ID: 27649560
[TBL] [Abstract][Full Text] [Related]
39. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
[TBL] [Abstract][Full Text] [Related]
40. The accuracy of cytology in diagnosis and DNA analysis of canine mammary tumours.
Hellmén E; Lindgren A
J Comp Pathol; 1989 Nov; 101(4):443-50. PubMed ID: 2607016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
